Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes
Author:
Affiliation:
1. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; Aurora Colorado
2. Pharmacy Practice, School of Pharmacy; MCPHS University; Boston Massachusetts
Funder
Sanofi
Publisher
Wiley
Subject
Pharmacology (medical)
Reference66 articles.
1. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond;Prasad-Reddy;Drugs Context,2015
2. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes;Kulve;Diabetologia,2015
3. Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes;DeFronzo;Diabetes Care,2013
4. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas;Smits;Diabetes Obes Metab,2016
5. Lixisenatide prescribing information 2016 www.accessdata.fda.gov/drugsatfda_docs/label/2016/208471Orig1s000lbl.pdf
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Peptide GLP-1 receptor agonists: From injection to oral delivery strategies;Biochemical Pharmacology;2024-11
2. Tirzepatide: A New Generation Therapeutic for Diabetes Type 2;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-07
3. GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes;Circulation;2022-12-13
4. Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities;Pharmacology & Therapeutics;2022-11
5. The Efficacy and Safety of the Combination Therapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis;Frontiers in Pharmacology;2022-02-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3